← Eichor
Study identifier: NCT06156943 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Advanced Goal-Directed Impedancemetry Strategy for Lung Resection Surgery

Condition: High-risk Lung Resection Surgery  ·  Sponsor: Hospices Civils de Lyon

PhaseNA
Planned participants722
Who can joinAll sexes, 18 Years to 80 Years
Healthy volunteersNo

About this study

High-risk patients scheduled for lung resection surgery are increasing and theoretically eligible to perioperative individualized goal-directed fluid therapy (GDFT). However, thoracic surgery is challenging for intraoperative stroke volume (SV) and/or cardiac output monitoring because it requires lateral positioning, one-lung ventilation, and open-chest condition. Pulse contour analysis and esophageal Doppler have been proposed with contrasting results, whereas dynamic indices have been shown useless for predicting fluid responsiveness in that specific setting. Besides, more invasive technologies like thermodilution are not routinely used at the bedside by careproviders. Chest bioreactance seems to be a feasible, safe, rustic, easy-to-use, and plug-and-play method to non-invasively and continuously monitor SV and cardiac output in thoracic cancer surgery patients, able to detect significant spontaneous and pharmacologically-induced changes over time. The impact of chest bioreactance on patients 'outcome remains however to be demonstrated. Indeed, the routine fluid management in patients undergoing lung resection surgery could be responsible of hypovolemia/hypoperfusion and/or hypervolemia/congestion leading to postoperative complications. The present national prospective multicenter randomized simple blind study aims to demonstrate that an individualized goal-directed fluid therapy (GDFT) driven by chest bioreactance improves outcomes within 30 days in lung resection surge…

This description comes directly from the study's public registry record.

Talk to the study team

FELLAHI Jean-Luc, M.D., Ph.D.,  ·  (+33) 4 72 11 89 33  ·  jean-luc.fellahi@chu-lyon.fr

SAMSON Géraldine  ·  (+33) 4.27.85.53.26  ·  Geraldine.samson@chu-lyon.fr

Always discuss trial participation with your own doctor first.

Locations (10)

Hopital Louis PradelBron, FranceRecruiting
CHU Dijon BourgogneDijon, FranceRecruiting
Hôpital Arnaud de Villeneuve - CHU MontpellierMontpellier, FranceRecruiting
Chu NancyNancy, FranceRecruiting
Hôpital Européen Georges PompidouParis, FranceRecruiting
Hopital du Haut-Leveque - CHU BordeauxPessac, FranceRecruiting
CHU de RennesRennes, FranceRecruiting
CHU NantesSaint-Herblain, FranceRecruiting
CHU StrasbourgStrasbourg, FranceRecruiting
Chu ToulouseToulouse, FranceRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06156943